Skip to main content

Table 3 Seven-day mortality risk analysis among CgPE cases (N = 196)

From: The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance

 

Univariate analysis

 

OR (95% CI)

P

Male

1.05 (0.32–3.44)

1.000

Age < 18 years

2.3 (0.26–20.38)

0.402

Age > 64 years

1.81 (0.22–14.62)

1.000

Urinary tract infection

0.3 (0.06–1.4)

0.133

Bloodstream infection

3.12 (0.95–10.25)

0.061

Respiratory tract infection

2.91 (0.9–9.48)

0.09

Intra-abdominal infection

0.47 (0.06–3.75)

0.695

Bone and soft tissue infection

1.02 (0.8–8.48)

1.000

Escherichia coli

2.21 (0.63–7.75)

0.253

Klebsiella pneumoniae

0.52 (0.11–2.46)

0.519

Enterobacter cloacae complex

1.14 (0.33–3.95)

1.000

Serratia marcescens

5.48 (0.53–57.14)

0.225

blaNDM, blaKPC

5.8 (1.36–24.82)

0.036

  1. OR odds ratio, CI confidence interval